The Manila Times

Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader

Dr. Laws, former immunology leader at Sanofi, will oversee global development of Kymera’s KT-621 program. KT-621 parallel Phase 2b trials advancing in AD and asthma, with data e ...
The Manila Times

Fredonia Provides El Dorado Monserrat Project and Corporate Update

Company completes approximately 3,500 meters of drilling, begins receiving assay results from its infill-focused program, continues advancing the PEA and strengthens development capabilities with the ...
JD Supra

Ottawa, Alberta and British Columbia Chart a Path Forward for a New West Coast Oil Pipeline

On July 2, 2026, the Canadian federal government, along with the provincial governments in Alberta and British Columbia, ...
TheLeafsNation

Tinus Luc Koblar draws parallel between World Championship experience and Norway’s World Cup run

Toronto Maple Leafs prospect Tinus Luc Koblar is taking in his second development camp fresh off of an impressive performance ...